Welcome to NewPressRelease.com a free press release service. Publishing press releases for Public Relations never been easier. Just register (it's free and it takes less then a 1 minute) then use Submit Press Release. Our services aim to help you reach journalists and to improve visibility in search engine listings, so you can get the most publicity possible.

Webinar On - Drug Master Files: New Implications under GDUFA

Events & Concerts

(Free Press Release) Compliance Trainings focuses on providing regulatory and quality web based online trainings to industry professionals across the globe. Compliance Trainings strives to educate and enhance the knowledge and broaden the horizons of regulatory professionals as well as professionals from the HR, Healthcare and many other industries. Regulatory compliance solutions from the house of Compliance Trainings strictly meet international standards and are fundamentally based on the objective of bringing down client compliance costs. Internationally scalable solutions are fully integrated into every webinar or event and help clients meet stringent demands of GxP, ISO and FDA regulatory authorities.

Webinar On - Drug Master Files: New Implications under GDUFA




Scheduled On : Thursday, January 23, 2014 at 13:00 Hrs

Description :

The Generic Drug User Fee Amendments of 2012 (GDUFA) were designed to speed the delivery of safe and effective generic drugs to the public and reduce costs to industry. A Drug Master File (DMF) is a submission to the Food and Drug Administration (FDA) that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs. This webinar will discuss the effect of GDUFA on the DMF process.

Although a DMF submission is not required by law or FDA regulation, it is often created to permit the FDA to review information in support of a third party’s submission without revealing the contents of the file to the third party. This maintains the confidentiality of proprietary information. DMFs usually cover the Chemistry, Manufacturing and Controls (CMC) of a drug product component (e.g., drug substance). The information contained in a DMF may be used to support an Investigational New Drug Application (IND), a New Drug Application (NDA), an Abbreviated New Drug Application (ANDA), another DMF, an Export Application, or amendments and supplements to any of these.

GDUFA enables FDA to assess user fees and bring greater predictability to the review of generic drug applications. The law requires industry to pay user fees to supplement the costs of reviewing generic drug applications and inspecting facilities. Additional resources enable FDA to reduce a current backlog of pending applications, cut the average time required to review generic drug applications for safety, and increase risk-based inspections. It is important to have an understanding of GDUFA and the new fees and requirements DMF holders must fulfill in order to achieve “Available for Reference” status. Only Abbreviated New Drug Application (ANDA) submissions which reference “Available for Reference” API DMFs can be received by FDA. Not having clarity on the new fees and requirements could cost your organization time, money, and other critical resources.

This webinar will help you have a better understanding of GDUFA, its implications regarding DMFs, who in industry is impacted, the required fees, and achieving DMF “Available for Reference” status.

Areas Covered in the Session :

  • GDUFA background
  • Key definitions
  • Who in industry is impacted
  • Self-identification and fee requirements
  • New DMF correspondences and meetings
  • Completeness assessments
  • “Available for Reference” status

Who Will Benefit:

  • Regulatory Affairs professionals
  • Project Managers
  • QA & QC Managers
  • API manufacturers
  • Generic drug manufacturers
  • Type II (API) DMF holders
  • ANDA sponsors
  • Consultants
  • Any individuals interested in the generic drug industry

Address:5939 Candlebrook Ct,
Mississauga, ON L5V 2V5,
Customer Support : 416-915-4458
This e-mail address is being protected from spambots. You need JavaScript enabled to view it





Webinar On - Drug Master Files: New Implications under GDUFA

Source: Press Release



If you have any questions regarding information in this press release, please contact the person listed as the Author or use the contact informations published in the press release. Please do not attempt to contact NewPressRelease.com. We are unable to assist you with any information regarding this release. NewPressRelease.com disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.

All press release information on this site, including free press releases, is solely based on what our users submit. NewPressRelease.com disclaims that any right and responsibility for the information goes to the user who submit the press release. Some press release may be confusing without additional explanation. You should contact the provider with any questions about the information presented. In case some press release damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.

Copyright © 2008 - 2018 Free Press Release by NewPressRelease.com